The move aims to curb the problem of people adding steroids to medicinal products like pharmacist-prescribed drug sets and unregistered traditional medicines, Prapon said. He warned that steroids could cause thinning of the gastrointestinal tract wall and bones and a sudden stop of usage could lead to hypotension, unconsciousness or death.
If the moves were insufficient, the FDA would further restrict the sale of steroids solely to hospitals, he said. If the two measures failed, FDA would get its 44 checkpoints nationwide to crack down on steroid smuggling.